INSP - ResMed Philips under pressure as Eli Lilly seeks sleep indication for weight loss drug
2024-06-22 08:27:42 ET
More on Eli Lilly, Philips, etc.
- Eli Lilly: The Party Is Probably Nearing The End
- Eli Lilly And Alzheimer's Disease: The Paucity Of Progress
- Eli Lilly: The Road To Approval Of Donanemab Is Open
- Lilly weight loss drug tirzepatide meets primary endpoint in sleep apnea study
- Hims & Hers defended at BofA as Lilly fights compounded GLP-1s